12.8 C
London
Friday, October 18, 2024
Subscribe
HomeTagsEisai

Tag: Eisai

spot_imgspot_img
Uncategorized

Eisai and ITO EN Enter Into Business Alliance Aiming to Support People Living with Dementia and to Prevent Dementia

Eisai Co., Ltd. and ITO EN, LTD. announced today that both parties have entered into a business alliance agreement concerning the initiatives for supporting...
Uncategorized

Japan – Eisai and National Cancer Center Commence Joint Research and Development Project

Eisai Co., Ltd. and the National Cancer Center Japan announced today that both parties have entered into a joint research and development (R&D)...
Uncategorized

Japan – Eisai: Application Submitted for Additional Indication of Anti Cancer Agent Lenvima in Combination With Keytruda as a Treatment for Advanced Uterine Body...

Eisai Co., Ltd. and MSD K.K., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., (known as MSD outside the United States...
Uncategorized

Japan – Eisai: 18-Month, Pre-Specified Analysis Showing Consistent Reduction in Clinical Outcome Measures from a Lecanemab (BAN2401) Phase 2b Clinical Trial in Early Alzheimer’s...

Eisai Co., Ltd. and Biogen Inc. today announced the publication of an article, A Randomized, Double-Blind Phase 2b Proof of Concept Clinical Trial...
Uncategorized

Japan – KYORIN and Eisai Enter Into License Agreement Concerning the Development and Marketing of Vibegron, a Treatment for Overactive Bladder, in Four ASEAN...

KYORIN Pharmaceutical Co., Ltd., a subsidiary of KYORIN Holdings, Inc., and Eisai Co., Ltd. have entered into a license agreement for development and...
Uncategorized

Japan – Eisai: Ministry of Health, Labour and Welfare Grants Orphan Drug Designation in Japan to Anti-Cancer Agent Lenvima (Lenvatinib) With Prospective Indication for...

Eisai Co., Ltd. announced today that it has received orphan drug designation for LENVIMA (generic name: lenvatinib mesylate), the orally available multiple receptor...
Uncategorized

Japan – Eisai: European Medicines Agency Accepts the Marketing Authorisation Applications for Two Additional Indications of Anti Cancer Agent Lenvatinib in Combination with Pembrolizumab

Eisai Co., Ltd. announced today that the European Medicines Agency (EMA) has confirmed it has accepted for review applications for the use of...
1...131415Page 14 of 15

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img

Company

Each template in our ever growing studio library can be added and moved around within any page effortlessly with one click.

Latest

Leaders Corporate Announces Strategic Partnership with Shomi to Implement Odoo ERP

Business 0
By integrating Odoo ERP, Leaders Corporate will consolidate essential...

Orgmytrip Launches Innovative Flight Booking Service to Enhance Travel Experience

Business 0
Travelers can now search, compare, and book flights from...

Skool O’ Foolz Kids Rap Group Drops Rapperz Delight on Spotify, Apple Music, Pandora, Amazon, Tidal, Napster, and Other Streaming Services

Business 0
Skool O' Foolz is a San Francisco based Gum...

Popular

Leaders Corporate Announces Strategic Partnership with Shomi to Implement Odoo ERP

Business 0
By integrating Odoo ERP, Leaders Corporate will consolidate essential...

Orgmytrip Launches Innovative Flight Booking Service to Enhance Travel Experience

Business 0
Travelers can now search, compare, and book flights from...

Skool O’ Foolz Kids Rap Group Drops Rapperz Delight on Spotify, Apple Music, Pandora, Amazon, Tidal, Napster, and Other Streaming Services

Business 0
Skool O' Foolz is a San Francisco based Gum...

Sitemap

© 2004-2024 Webnewswire, All Rights Reserved